Sam Behjati | Wellcome Trust Intermediate Clinical Fellow

Behjati, Sam

I am a Wellcome Trust Intermediate Clinical Fellow based at Sanger and the University Department of Paediatrics (Cambridge). My research aims to utilise sequencing technologies to understand the basis of childhood cancers within the context of normal cells and human development. My research is funded by the Wellcome Trust and the St. Baldrick's Foundation.


  • Retracing embryological fate.

    Behjati S

    Science (New York, N.Y.) 2016;354;6316;1109

  • Mutational signatures of ionizing radiation in second malignancies.

    Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS et al.

    Nature communications 2016;7;12605

  • Genome sequencing of normal cells reveals developmental lineages and mutational processes.

    Behjati S, Huch M, van Boxtel R, Karthaus W, Wedge DC et al.

    Nature 2014;513;7518;422-425

  • Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

    Behjati S, Tarpey PS, Sheldon H, Martincorena I, Van Loo P et al.

    Nature genetics 2014;46;4;376-379

  • Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

    Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N et al.

    Nature genetics 2013;45;12;1479-82

  • Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.

    Tarpey PS, Behjati S, Cooke SL, Van Loo P, Wedge DC et al.

    Nature genetics 2013;45;8;923-6

Behjati, Sam
Sam's Timeline

Science & SciLifeLab Prize for Young Scientists (Genomics category)

Robert J. Arceci Innovation Award | St. Baldrick’s Foundation

Wellcome Trust Intermediate Clinical Fellowship | Sanger | University Department of Paediatrics, Cambridge


Donald Paterson Prize | Royal College of Paediatrics and Child Health


PhD - Wellcome Trust Clinical Research Fellowship | Sanger | University of Cambridge


Academic Clinical Fellow | UCL Great Ormond Street Institute of Child Health


BMBCh | University of Oxford